by Zoe Dimond | Jun 5, 2026
by Rob Copenhaver | Mar 29, 2019
Novel HCV Antiviral Screening in FRG Mice Identification of a New Benzimidazole Derivative as an Antiviral Against Hepatitis C Virus Vausselin et. al., 2016 Study Summary In recent years, HCV therapy has been profoundly improved with the approval of direct-acting...
by Rob Copenhaver | Mar 29, 2019
HEV Infection in FRG Mice from Patient Plasma Transmission of Hepatitis E Virus Infection to Human-liver Chimeric FRG Mice Using Patient Plasma Sayed et. al., 2017 Study Summary Hepatitis E virus (HEV) is considered as an important pathogen in developing countries....
by Rob Copenhaver | Mar 29, 2019
Efficacy of Ribonuclease H Inhibitors for HBV Infection in FRG Mice Efficacy of Hepatitis B Virus Ribonuclease H Inhibitors, a New Class of Replication Antagonists, in FRG Human Liver Chimeric Mice Long et. al., 2018 Study Summary Hepatitis B infections can be studied...
by Rob Copenhaver | Mar 29, 2019
Recapitulation of Treatment Response to HBV Infection in FRG Mice Recapitulation of Treatment Response Patterns in a Novel Humanized Mouse Model for Chronic Hepatitis B Virus Infection Winer et. al., 2017 Study Summary Hepatitis B virus only has a limited host...
